Category Archives: Uncategorized

This phase 2 study reports the safety and efficacy of faricimab for diabetic macular edema (DME). Source: AAO

• Posted on: Oct 16 2019
• By: Saratoga Opthalmology
• Leave a response

Investigators identified patient characteristics associated with follow-up compliance after cataract surgery. Source: AAO

• Posted on: Oct 10 2019
• By: Saratoga Opthalmology
• Leave a response

Investigators assessed the safety and efficacy of Schlemm canal stenting in combination with cataract surgery in eyes with mild to moderate primary open-angle glaucoma (POAG). Source: AAO

• Posted on: Oct 9 2019
• By: Saratoga Opthalmology
• Leave a response

Novartis’ brolucizumab (Beovu) is now FDA approved for the treatment of wet AMD, the company reported today. Source: AAO

• Posted on: Oct 9 2019
• By: Saratoga Opthalmology
• Leave a response

Researchers evaluated pharmacologic treatment options for visual snow and reported the prevalence of comorbid diseases. Source: AAO

• Posted on: Oct 8 2019
• By: Saratoga Opthalmology
• Leave a response

Investigators report the long-term results of accelerated corneal collagen crosslinking (CXL) treatment in adolescent patients with progressive keratoconus. Source: AAO

• Posted on: Oct 7 2019
• By: Saratoga Opthalmology
• Leave a response

This systematic review describes the efficacy of conventional and biologic disease-modifying antirheumatic drugs in IgG4-related orbital disease. Source: AAO

• Posted on: Oct 4 2019
• By: Saratoga Opthalmology
• Leave a response

This week, a classic card game gets a Braille makeover, researchers call for additional chocolate to confirm its visual benefits and Novartis partners with Microsoft on AI for macular degeneration. Source: AAO

• Posted on: Oct 4 2019
• By: Saratoga Opthalmology
• Leave a response

This study examined the mechanism of corneal hydrops in eyes with keratoconus. Source: AAO

• Posted on: Oct 3 2019
• By: Saratoga Opthalmology
• Leave a response

This review describes the clinical features that distinguish between major immune-mediated and inflammatory syndromes affecting the brainstem, many of which have ophthalmic effects. Source: AAO

• Posted on: Oct 3 2019
• By: Saratoga Opthalmology
• Leave a response